Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo
DGX agentThe Coalition for Epidemic Preparedness Innovations (CEPI) announced an expanded collaboration with Moderna, committing up to $50 million to support preclinical development and Phase 1 clinical testin